Paper9083333
Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice.
Rentsch KM and 4 others. Br J Cancer, 1997. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. Papers, record 9083333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9083333
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Mitoxantrone | Major topic |
| Animals | |
| Female | |
| Humans | |
| Mice | |
| Mice, Inbred Strains | |
| Neoplasm Transplantation | |
| Neoplasms, Experimental | |
| Tissue Distribution | |
| Transplantation, Heterologous |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1676658 | Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations. | Drug Metab Dispos | 1991 | https://conductscience.org/library/papers/1676658 | PubMed |
| 2 | 2013113 | Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/2013113 | PubMed |
| 3 | 1764871 | Pharmacokinetic optimisation of anticancer therapy. | Clin Pharmacokinet | 1991 | https://conductscience.org/library/papers/1764871 | PubMed |
| 4 | 1737351 | Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. | Cancer Res | 1992 | https://conductscience.org/library/papers/1737351 | PubMed |
| 5 | 1686230 | Evidence for oxidative activation of mitoxantrone in human, pig, and rat. | Drug Metab Dispos | 1991 | https://conductscience.org/library/papers/1686230 | PubMed |
| 6 | 1568796 | Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. | Int J Cancer | 1992 | https://conductscience.org/library/papers/1568796 | PubMed |
| 7 | 1596882 | Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. | Cancer Res | 1992 | https://conductscience.org/library/papers/1596882 | PubMed |
| 8 | 8321835 | Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. | Pharm Res | 1993 | https://conductscience.org/library/papers/8321835 | PubMed |
| 9 | 8998559 | Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatography. | J Chromatogr B Biomed Appl | 1996 | https://conductscience.org/library/papers/8998559 | PubMed |
| 10 | 1711446 | Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. | Drugs | 1991 | https://conductscience.org/library/papers/1711446 | PubMed |
| 11 | 6375887 | Detection and quantification of mitoxantrone in human organs. A case report. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6375887 | PubMed |
| 12 | 3978648 | Disposition of mitoxantrone in cancer patients. | Cancer Res | 1985 | https://conductscience.org/library/papers/3978648 | PubMed |
| 13 | 3979268 | Comment on mitoxantrone. | Drug Intell Clin Pharm | 1985 | https://conductscience.org/library/papers/3979268 | PubMed |
| 14 | 3839135 | Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. | Biochim Biophys Acta | 1985 | https://conductscience.org/library/papers/3839135 | PubMed |
| 15 | 4040505 | Pharmacology of mitoxantrone: mode of action and pharmacokinetics. | Invest New Drugs | 1985 | https://conductscience.org/library/papers/4040505 | PubMed |
| 16 | 3484382 | Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3484382 | PubMed |
| 17 | 3941019 | Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes. | Int J Cancer | 1986 | https://conductscience.org/library/papers/3941019 | PubMed |
| 18 | 3964703 | Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. | Biochim Biophys Acta | 1986 | https://conductscience.org/library/papers/3964703 | PubMed |
| 19 | 3521429 | Mitoxantrone: a new anticancer drug with significant clinical activity. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/3521429 | PubMed |
| 20 | 3768871 | Human autopsy tissue concentrations of mitoxantrone. | Cancer Treat Rep | 1986 | https://conductscience.org/library/papers/3768871 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27601896 | Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition. | Int J Nanomedicine | 2016 | https://conductscience.org/library/papers/27601896 | PubMed |
| 24961369 | Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24961369 | PubMed |
| 23049558 | Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine. | Adv Hematol | 2012 | https://conductscience.org/library/papers/23049558 | PubMed |
| 22451016 | A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding. | AAPS J | 2012 | https://conductscience.org/library/papers/22451016 | PubMed |
| 20369276 | Effects of single and multiple flavonoids on BCRP-mediated accumulation, cytotoxicity and transport of mitoxantrone in vitro. | Pharm Res | 2010 | https://conductscience.org/library/papers/20369276 | PubMed |
| 11494116 | Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. | Neoplasia | 2001 | https://conductscience.org/library/papers/11494116 | PubMed |
| 10933074 | Applications of magnetic resonance in model systems: cancer therapeutics. | Neoplasia | 2000 | https://conductscience.org/library/papers/10933074 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9083333
GET https://conductscience.org/api/papers/v1/9083333/references?page=2